Historical Stock Price
XBIO historical stock prices picture
Xenetic Biosciences (XBIO) has the following price history information. Looking back at XBIO historical stock prices for the last five trading days, on May 01, 2024, XBIO opened at $4.34, traded as high as $4.34 and as low as $3.82, and closed at $4.13. Trading volume was a total of 3.50K shares. On May 02, 2024, XBIO opened at $3.95, traded as high as $4.02 and as low as $3.90, and closed at $3.90. Trading volume was a total of 1.00K shares. On May 03, 2024, XBIO opened at $3.85, traded as high as $4.27 and as low as $3.81, and closed at $4.27. Trading volume was a total of 5.70K shares. On May 06, 2024, XBIO opened at $3.85, traded as high as $4.19 and as low as $3.81, and closed at $3.96. Trading volume was a total of 10.90K shares. On May 07, 2024, XBIO opened at $4.20, traded as high as $4.20 and as low as $3.85, and closed at $3.85. Trading volume was a total of 3.40K shares.

XBIO Historical Stock Prices By Date:

XBIO historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Xenetic Biosciences shares, starting with a $10,000 purchase of XBIO, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 06/30/2016
End date: 05/07/2024
Start price/share: $612.00
End price/share: $3.85
Dividends collected/share: $0.00
Total return: -99.37%
Average Annual Total Return: -47.54%
Starting investment: $10,000.00
Ending investment: $62.88
Years: 7.86
Date Open High Low Close Volume
05/01/2024 $4.34 $4.34 $3.82 $4.13 3.50K
05/02/2024 $3.95 $4.02 $3.90 $3.90 1.00K
05/03/2024 $3.85 $4.27 $3.81 $4.27 5.70K
05/06/2024 $3.85 $4.19 $3.81 $3.96 10.90K
05/07/2024 $4.20 $4.20 $3.85 $3.85 3.40K
Xenetic Biosciences is a biopharmaceutical company. Co.'s drug candidates pipeline include: XCART, which is a CAR T cell platform technology engineered to target patient-specific tumor neoantigens; ErepoXen (polysialylated erythropoietin), which uses Co.'s PolyXen platform technology for the treatment of anemia in chronic kidney disease patients; XBIO-101, which is an internal candidate with orphan drug designation from the U.S. Food and Drug Administration for the potential treatment of progesterone receptor negative endometrial cancer in conjunction with progesterone therapy; and OncoHist, which utilizes the properties of modified human histone H1.3 for targeted cell killing.
Date Close
05/01/2024$4.13
05/02/2024$3.90
05/03/2024$4.27
05/06/2024$3.96
05/07/2024$3.85
XBIO is categorized under the Healthcare sector; below are some other companies in the same sector:

XENT Historical Stock Prices
XLRN Historical Stock Prices
XNCR Historical Stock Prices
XNPT Historical Stock Prices
XOMA Historical Stock Prices
XON Historical Stock Prices
XRAY Historical Stock Prices
XTNT Historical Stock Prices
YCC Historical Stock Prices
ZBH Historical Stock Prices

Also explore: XBIO shares outstanding history

Email EnvelopeFree XBIO Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts


XBIO Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.